A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
